AMICUS THERAPEUTICS, INC. Current Foreign Tax Expense (Benefit)
AMICUS THERAPEUTICS, INC. reported Current Foreign Tax Expense (Benefit) of $27.27 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentForeignTaxExpenseBenefit · last filed 2026-02-20
- AMICUS THERAPEUTICS, INC. current foreign tax expense (benefit) for fiscal 2025 was $27.27M, a 0.01% decline from fiscal 2024.
- AMICUS THERAPEUTICS, INC. current foreign tax expense (benefit) for fiscal 2024 was $27.27M, a 325.62% increase from fiscal 2023.
- AMICUS THERAPEUTICS, INC. current foreign tax expense (benefit) for fiscal 2023 was $6.41M.
- AMICUS THERAPEUTICS, INC. current foreign tax expense (benefit) for fiscal 2022 was -$5.76M, a 165.03% decline from fiscal 2021.
| Period end | Current Foreign Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $27.27M 10-K · filed 2026-02-20 |
| 2024-12-31 | $27.27M 10-K · filed 2026-02-20 |
| 2023-12-31 | $6.41M 10-K · filed 2026-02-20 |
| 2022-12-31 | -$5.76M 10-K · filed 2025-02-19 |
| 2021-12-31 | $8.86M 10-K · filed 2024-02-28 |
| 2020-12-31 | $4.16M 10-K · filed 2023-03-01 |
| 2019-12-31 | $2.88M 10-K · filed 2022-02-24 |
| 2018-12-31 | -$100.00K 10-K · filed 2021-03-01 |
| 2017-12-31 | $2.28M 10-K · filed 2020-03-02 |
| 2016-12-31 | $0.00 10-K · filed 2019-02-28 |